Detection of telomerase activity and hTERT mRNA expression and its application for the diagnosis of gynecologic tumors
Detection of telomerase activity and hTERT mRNA expression and its application for the diagnosis of gynecologic tumors
批准号:
11671604
负责人:
KYO Satoru
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Telomerase is a cellular reverse transcriptase which catalyzes the synthesis and extension of telomeric DNA.This enzyme is specifically activated in most malignant tumors, but is usually inactive in normal somatic cells, and within which telomeres therefore progressively shorten with cell division. A mechanism to maintain telomere stability is required for the cells to overcome replicative senescence, and telomerase activation may therefore be a rate-limiting or critical step in cellular immortality and oncogenesis. Human telomerase reverse transcriptase (hTERT) is a catalytic subunit protein of telomerase and is a critical determinant of its enzymatic activity.In the present study, we examined the utility of detecting telomerase activity and hTERT mRNA expression for the diagnosis and screening of gynecologyc tumors. We found that most gynecologic cancers express telomerase activity while the corresponding normal tissues do not. Cervical and endometrial exfoliated cells were collected from the patients with or without cervical or endometrial lesions and telomerase activity and hTERT mRNA expression were detected by the TRAP assays or RT-PCR assays. Approximately 90% of the patients with cervical or endometrial cancer were positive for telomerase activity or hTERT mRNA expression, while less than 10% of those without any lesions were so. 50 to 60% of the patients with premalignant lesions, such as suqamous intraepithelial lesions (SIL) expressed telomerase activity or hTERT mRNA.These findings suggest that detection of telomerase activity or hTERT mRNA expression may be an useful tool for cancer diagnosis and screening.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kyo S, Takakura M, Kanaya T, Wang Zhuo, Fujimoto K, Nishio Y, Orimo A, Inoue M.: "Estrogen activates telomerase."Cancer Res. 59. 5917-5921 (1999)
Kyo S、Takakura M、Kanaya T、Wang Zhuo、Fujimoto K、Nishio Y、Orimo A、Inoue M.:“雌激素激活端粒酶。”癌症研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wang Z,Kyo S et al: "Progesterone regulates hTERT gene expression via activation of MAP Kinase signaling pathway"Cancer Research. 60. 5376-5381 (2000)
Wang Z,Kyo S 等人:“黄体酮通过激活 MAP 激酶信号通路调节 hTERT 基因表达”癌症研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kyo, S et al: "Estrogen activates telomerase"Cancer Research. 59. 5917-5921 (1999)
Kyo, S 等人:“雌激素激活端粒酶”癌症研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takakura.M,Kyo S et al: "Cloning of hTERT gene promoter and identification of proximal core promoter essential for transcriptional activation in immortalized and cancer cells"Cancer Research. 59. 551-557 (1999)
Takakura.M、Kyo S 等人:“hTERT 基因启动子的克隆和永生化细胞和癌细胞中转录激活所必需的近端核心启动子的鉴定”癌症研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kyo S. et al: "Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT) "Nucleic Acids Research. 28. 669-677 (2000)
Kyo S. 等人:“Sp1 与 c-Myc 合作激活人类端粒酶逆转录酶基因 (hTERT) 的转录”核酸研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
Exploration of molecular targets for endometriosis-associated ovarian cancer with in vitro multistep carcinogenesis model
-
批准号:23390387
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2011
-
负责人:KYO Satoru
-
依托单位:
Identification of molecular mechanisms and the targets using in vitro carcinogenesis model of endometrial cancer.
-
批准号:20390432
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.31万
-
财政年份:2008
-
负责人:KYO Satoru
-
依托单位:
Establishment of novel cancer therapy using telomerase-specific replication competent adenovirus
-
批准号:17390449
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.44万
-
财政年份:2005
-
负责人:KYO Satoru
-
依托单位:
Establishment of novel molecular cancer therapy targeting telomerase and its clinical appication to gynecologic tumors
-
批准号:15390501
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.56万
-
财政年份:2003
-
负责人:KYO Satoru
-
依托单位:
Establishment of novel gene therapy targeting gynecologic tumors
-
批准号:13557138
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.72万
-
财政年份:2001
-
负责人:KYO Satoru
-
依托单位:
Establishment of telomerase-based novel gene therapy and diagnosis for gynecologic tumors
-
批准号:13671702
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2001
-
负责人:KYO Satoru
-
依托单位:
Mechanisms of human papillomavirus E6/E7 expression during cellular differentialtion of cervical cancer
-
批准号:08671876
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1996
-
负责人:KYO Satoru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
人端粒酶逆转录酶(hTERT)对胶质瘤细胞增殖及凋亡影响的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
响应型MRI靶向引导温控hTERT-shRNA生成用于乳腺癌的早期精准诊疗
-
批准号:32301196
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:张亮
-
依托单位:
DARS2促进hTERT进入线粒体在肝癌增殖侵袭中的作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
基于hTERT promoter突变的脑胶质瘤分子异质性可视化及靶向的研究
-
批准号:82373403
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:程也
-
依托单位:
TIMM50介导hTERT线粒体转位的分子机制及其在胃癌化疗耐药中的作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:户维超
-
依托单位:
YBX1通过识别hTERT-m5C修饰增强hTERTmRNA稳定性促进结肠癌细胞侵袭的分子机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:龚春丽
-
依托单位:
circSATB1介导hTERT调控急性髓系白血病细胞衰老的作用和机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:方玉
-
依托单位:
MED13介导的TRIP4/hTERT信号通路在维持肺癌干细胞干性中的作用及机制研究
-
批准号:82103667
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:车懿霖
-
依托单位:
DDB2靶向上调KMT2A/hTERT通路促进黑色素瘤生长的分子机制及临床意义
-
批准号:82002899
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:张昌林
-
依托单位:
珠三角地区大气细颗粒物及其组分与hTERT基因多态性的交互作用对肺癌不良生存结局的影响
-
批准号:2020A1515010132
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2020
-
负责人:于红瑶
-
依托单位: